Mutant IDH1-IN-2
| CAS No. | 1429176-69-1 | Cat. No. | BCP16464 |
| Name | Mutant IDH1-IN-2 | ||
| Synonyms | 2-Oxazolidinone, 3-[2-[[(1S)-1-[4-[(4,4-difluoro-1-piperidinyl)methyl]phenyl]ethyl]amino]-4-pyrimidinyl]-4-(1-methylethyl)-, (4S)-; | ||
| Formula | C24H31F2N5O2 | M. Wt | 459.53 |
| Description | Mutant IDH1-IN-2 has a neomorphic activity and in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer. More bioactivity information in Patent WO 2013046136A1. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | IDH | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.